Identification of an isomer impurity in piperaquine drug substance.
A significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]propane) has been identified using liquid chromatography-mass spectrometry (LC-MS) and 2D NMR spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the position...
Váldodahkkit: | , , , , , , , , |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2006
|
_version_ | 1826305692780199936 |
---|---|
author | Lindegårdh, N Giorgi, F Galletti, B Di Mattia, M Quaglia, M Carnevale, D White, N Mazzanti, A Day, N |
author_facet | Lindegårdh, N Giorgi, F Galletti, B Di Mattia, M Quaglia, M Carnevale, D White, N Mazzanti, A Day, N |
author_sort | Lindegårdh, N |
collection | OXFORD |
description | A significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]propane) has been identified using liquid chromatography-mass spectrometry (LC-MS) and 2D NMR spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the positional isomer 1-[(5-chloroquinolin-4)-piperazinyl]-3-[(7-chloroquinolin-4)-piperazinyl]propane. The impurity is formed because of contamination of batches of 4,7-dichloroquinoline (a precursor in the synthesis of piperaquine) with 4,5-dichloroquinoline. The amount of impurity (peak area impurity/peak area piperaquine using LC-UV at 347 nm) in old batches of piperaquine and in Artekin (the combination of dihydroartemisinin-piperaquine) ranged from 1.5 to 5%. |
first_indexed | 2024-03-07T06:36:42Z |
format | Journal article |
id | oxford-uuid:f7e59c98-9ddb-4a5c-8cf5-20a30ee30bef |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:36:42Z |
publishDate | 2006 |
record_format | dspace |
spelling | oxford-uuid:f7e59c98-9ddb-4a5c-8cf5-20a30ee30bef2022-03-27T12:46:07ZIdentification of an isomer impurity in piperaquine drug substance.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f7e59c98-9ddb-4a5c-8cf5-20a30ee30befEnglishSymplectic Elements at Oxford2006Lindegårdh, NGiorgi, FGalletti, BDi Mattia, MQuaglia, MCarnevale, DWhite, NMazzanti, ADay, NA significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]propane) has been identified using liquid chromatography-mass spectrometry (LC-MS) and 2D NMR spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the positional isomer 1-[(5-chloroquinolin-4)-piperazinyl]-3-[(7-chloroquinolin-4)-piperazinyl]propane. The impurity is formed because of contamination of batches of 4,7-dichloroquinoline (a precursor in the synthesis of piperaquine) with 4,5-dichloroquinoline. The amount of impurity (peak area impurity/peak area piperaquine using LC-UV at 347 nm) in old batches of piperaquine and in Artekin (the combination of dihydroartemisinin-piperaquine) ranged from 1.5 to 5%. |
spellingShingle | Lindegårdh, N Giorgi, F Galletti, B Di Mattia, M Quaglia, M Carnevale, D White, N Mazzanti, A Day, N Identification of an isomer impurity in piperaquine drug substance. |
title | Identification of an isomer impurity in piperaquine drug substance. |
title_full | Identification of an isomer impurity in piperaquine drug substance. |
title_fullStr | Identification of an isomer impurity in piperaquine drug substance. |
title_full_unstemmed | Identification of an isomer impurity in piperaquine drug substance. |
title_short | Identification of an isomer impurity in piperaquine drug substance. |
title_sort | identification of an isomer impurity in piperaquine drug substance |
work_keys_str_mv | AT lindegardhn identificationofanisomerimpurityinpiperaquinedrugsubstance AT giorgif identificationofanisomerimpurityinpiperaquinedrugsubstance AT gallettib identificationofanisomerimpurityinpiperaquinedrugsubstance AT dimattiam identificationofanisomerimpurityinpiperaquinedrugsubstance AT quagliam identificationofanisomerimpurityinpiperaquinedrugsubstance AT carnevaled identificationofanisomerimpurityinpiperaquinedrugsubstance AT whiten identificationofanisomerimpurityinpiperaquinedrugsubstance AT mazzantia identificationofanisomerimpurityinpiperaquinedrugsubstance AT dayn identificationofanisomerimpurityinpiperaquinedrugsubstance |